0000939767-20-000107.txt : 20200722
0000939767-20-000107.hdr.sgml : 20200722
20200722190619
ACCESSION NUMBER: 0000939767-20-000107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200720
FILED AS OF DATE: 20200722
DATE AS OF CHANGE: 20200722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISSEY MICHAEL
CENTRAL INDEX KEY: 0001202096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 201042427
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL M
DATE OF NAME CHANGE: 20030512
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL R
DATE OF NAME CHANGE: 20021029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_159545916437063.xml
FORM 4
X0306
4
2020-07-20
0
0000939767
EXELIXIS, INC.
EXEL
0001202096
MORRISSEY MICHAEL
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
1
0
0
President and CEO
Common Stock
2020-07-14
5
G
0
E
35559
0
D
85985
D
Common Stock
2020-07-14
5
G
0
E
35559
0
A
995772
I
By Trust
Common Stock
2020-07-20
4
M
0
100000
6.21
A
185985
D
Common Stock
2020-07-20
4
F
0
64137
25.60
D
121848
D
Common Stock
2020-07-22
5
G
0
E
35863
0
D
85985
D
Common Stock
2020-07-22
5
G
0
E
35863
0
A
1031635
I
By Trust
Common Stock
17728
I
By 401(k)
Option (right to buy)
6.21
2020-07-20
4
M
0
100000
0
D
2016-09-16
2022-09-15
Common Stock
100000.0
0
D
On July 14, 2020, the Reporting Person gifted 35,559 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.
Includes 85,985 shares of Exelixis, Inc. Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,863 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,137 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on July 20, 2020 of $25.60.
On July 22, 2020, the Reporting Person gifted 35,863 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of July 20, 2020.
The option, representing the right to purchase a total of 500,000 shares of Common Stock, became fully exercisable on September 16, 2019.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2020-07-22